Cholera vaccine shortage forces one-dose strategy: WHO
Shortage of cholera vaccines forces global agencies to shift to single doses instead of recommended two
Drugs
Medical
Drugs
Medical
‘Universal’ Covid-19 treatment may be on the horizon
October 19, 2022: Researchers at Oregon State University have developed a proof of principle for a “universal” method of treating Covid-19. According to.
Drugs
Pharma
Gavi, Moderna sign pact for Covid-19 vaccines
HQ Team October 18, 2022: Gavi, a public-private partnership Vaccine Alliance, has signed a new pact with Moderna to supply Covid-19 vaccines to low-income countries..
Drugs
Medical
Pharma
BioNTech founders hopeful of a cancer vaccine within a decade
Scientists are hopeful of an mRNA based vaccine for cancer
Drugs
Pharma
Biocon signs out-licencing pact with Yoshindo
HQ Team October 17, 2022: Biocon Biologics, a subsidiary of India’s Biocon, has inked an out-licencing pact with Japan’s Yoshindo Inc for selling.
Drugs
Pharma
Adderall shortage due to Teva Pharma manufacturing delays
FDA confirms Adderall shortage due to problems in Teva Pharma's supply pipeline
Drugs
Pharma
Merck pays Moderna $250m for joint development of skin cancer vaccine
Moderna’s mRNA vaccine is being studied in combination with Merck’s Keytruda to treat patients with high-risk melanoma
Drugs
Medical
Pharma
Neumora Therapeutics raises $112 million in series B to fund neuro disorder research
Neumora Therapeutics raises $650 million to date to revolutionize treatment of brain diseases
Drugs
Pharma
Stalicla signs license deal for Evgens’ SFX-01
Evgen Pharma and Stalicla sign a $165 million licensing deal for neuro development disorder SFX-01 asset
Drugs
Pharma
Merck’s Covid-19 pill fails initial trial; AstraZenaca’s nasal spray too ineffective
Merck's Covid-19 pill no help in reducing hospitalization or death, Astrazenaca's nasal spray too fails trial